Published Date:2023-01-17 Original Link:https://www.onenessbio.com/en/news_detail196_5.htm No 2 Date of announcement 2023/01/17 Time of announcement 18:28:34 Subject An U.S. patent titled “METHOD FOR PREPARING PLECTRANTHUS AMBOINICUS FRACTION HAVING ANTI-ARTHRITIS ACTIVITY” has been granted. To which item it meets paragraph 53 Date of events 2023/01/17 Statement Date of occurrence of the event:2023/01/17 Company name:ONENESS BIOTECH CO., LTD. Relationship...Read More
Published Date:2023-01-13 Original Link:https://www.onenessbio.com/en/news_detail195_5.htm No 1 Date of announcement 2023/01/13 Time of announcement 15:16:40 Subject The CEA of Fespixon based on its significant clinical efficacy showed its cost-effectiveness for treating DFUs. The manuscript was published by JAMA Network Open To which item it meets paragraph 53 Date of events 2023/01/13 Statement Date of occurrence of...Read More
Published Date:2023-01-11 Original Link:https://www.onenessbio.com/en/news_detail194_5.htm No 1 Date of announcement 2023/01/11 Time of announcement 01:54:34 Subject The exploratory trial result of Fespixon in improving postoperative scar cosmesis has been published by a renowned SCI journal, Aesthetic Surgery Journal. To which item it meets paragraph 53 Date of events 2023/01/10 Statement Date of occurrence of the event:2023/01/10...Read More
Date 2022/12/28 Location Online Presentation Download Download Chinese Version Download English Version Video Recording (English interpretation) Note N/ARead More
Published Date:2022-12-23 Original Link:https://www.onenessbio.com/en/news_detail193_1.htm No 1 Date of announcement 2022/12/23 Time of announcement 17:19:54 Subject Oneness Biotech to Present at the 41st Annual J.P. Morgan Healthcare Conference To which item it meets paragraph 12 Date of events 2023/01/11 Statement Date of institutional investor conference: 2023/01/11 Time of institutional investor conference: 08:00 (CST) Location of institutional...Read More
Published Date:2022-12-21 Original Link:https://www.onenessbio.com/en/news_detail192_1.htm No 1 Date of announcement 2022/12/21 Time of announcement 17:12:56 Subject Oneness and Microbio (Shanghai) signed an agreement with Cho Pharma to jointly develop glycosylation-based nucleic acid delivery technology. To which item it meets paragraph 12 Date of events 2022/12/28 Statement Date of institutional investor conference:2022/12/28 Time of institutional investor conference:15:00...Read More
